Abstract
References
Articles referenced by this article (15)
Specificity of the Calgary Depression Scale for schizophrenics.
Schizophr Res, (3):239-244 1994
MED: 8193062
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.
Schizophr Bull, (3):388-398 1984
MED: 6474101
Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis.
Schizophr Bull, (4):813-825 2004
MED: 15957198
The NIMH-MATRICS consensus statement on negative symptoms.
Schizophr Bull, (2):214-219 2006
MED: 16481659
Regulatory issues
2002
The quality of life interview for the severe mentally ill
Eval. Program Plann. 1988
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
N Engl J Med, (12):1209-1223 2005
MED: 16172203
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
J Clin Psychiatry, (12):538-546 1997
MED: 9448657
Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients.
J Neuropsychiatry Clin Neurosci, (2):257-264 2000
MED: 11001606
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
Am J Psychiatry, (3):495-506 2005
MED: 15741466
Show 5 more references (10 of 15)
Citations & impact
Impact metrics
Article citations
Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data.
Mol Neurobiol, 61(8):5992-6012, 24 Jan 2024
Cited by: 0 articles | PMID: 38267752
Violent behavior and the network properties of psychopathological symptoms and real-life functioning in patients with schizophrenia.
Front Psychiatry, 14:1324911, 11 Jan 2024
Cited by: 0 articles | PMID: 38274426 | PMCID: PMC10808501
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
PLoS One, 18(9):e0288354, 21 Sep 2023
Cited by: 2 articles | PMID: 37733693 | PMCID: PMC10513234
Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis.
BMC Psychiatry, 23(1):595, 15 Aug 2023
Cited by: 1 article | PMID: 37582728 | PMCID: PMC10428523
Personal barriers to participation in chosen instrumental activities of daily living among community-dwelling persons with schizophrenia in Rwanda.
Afr J Disabil, 12:1063, 28 Jun 2023
Cited by: 0 articles | PMID: 37435191 | PMCID: PMC10331024
Go to all (152) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study.
Schizophr Res, 151(1-3):203-208, 01 Nov 2013
Cited by: 22 articles | PMID: 24183751
Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
Schizophr Res, 134(2-3):195-201, 21 Oct 2011
Cited by: 19 articles | PMID: 22019076
Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis.
Schizophr Res, 150(2-3):339-342, 27 Jul 2013
Cited by: 55 articles | PMID: 23899997
[Incidence of the deficit form in refractory schizophrenia].
Encephale, 22 Spec No 2:19-23, 01 Jun 1996
Cited by: 2 articles | PMID: 8767037
Review
Funding
Funders who supported this work.
National Institute of Mental Health (1)
Grant ID: N01MH90001